Lung Neoplasm Malignant

Oncology·MeSH: Lung Neoplasms

5 drugs in development·1 company·4 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
Acetaminophen	Merck & Co., Inc. (MRK)
H1 receptor antagonist	Merck & Co., Inc. (MRK)
H2 receptor antagonist	Merck & Co., Inc. (MRK)
MK-1084	Merck & Co., Inc. (MRK)
Patritumab deruxtecan	Merck & Co., Inc. (MRK)

Compare drugs

Acetaminophen vs H1 receptor antagonist Acetaminophen vs H2 receptor antagonist Acetaminophen vs MK-1084

Frequently asked questions

How many drugs are in development for Lung Neoplasm Malignant?

BioSniper tracks 5 drugs in development for Lung Neoplasm Malignant across 1 company.

How many clinical trials target Lung Neoplasm Malignant?

There are 4 clinical trials targeting Lung Neoplasm Malignant tracked by BioSniper.

Deep-dive into Lung Neoplasm Malignant

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Lung Neoplasm Malignant — Drugs in Development & Clinical Trials | BioSniper